×
Login Register an account
Top Submissions Explore Upgoat Search Random Subverse Random Post Colorize! Site Rules Donate
10
17 comments block

The new therapy involves programming the patient's peripheral blood mononuclear cells, transforming them into "seed cells" to recreate pancreatic islet tissue in an artificial environment.

So long diabetes, hello pancreatic cancer! The question for big pharma is: do we make more money from insulin or the cancer treatments? I'm sure actuaries are crunching the numbers as we speak.